Copyright Licensing Agency releases new Pharmaceutical Collaboration Licence

more+
less-

Companies holding an existing Pharmaceutical Licence from the Copyright Licensing Agency (“CLA“) have been given the opportunity to upgrade to a new Trial Pharmaceutical Collaboration Licence (“TPCL“), at no extra cost.  The TPCL will enable licensed companies to legally share copies of material from CLA covered publications with similarly licensed organisations on projects or products where they are working collaboratively. 

The TPCL is designed to offer existing licence holders extended permissions to enjoy the benefits of sharing in an industry which relies heavily on collaboration between companies in the development of new products.  

The TPCL has be introduced on a trial basis and feedback will be requested from licensees later this year for any suggested improvements. 

Further information on the TPCL and how to apply can be found on the CLA website.  The CLA has also published FAQs which can be found here.

 

Written by:

Published In:

UK

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© DLA Piper | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×
×